We report here that remote injections of f-hPSCs, consisting predominantly of fetal placental cells, both by intramuscular (IM) or subcutaneous (SC) injections, following TBI with high dose of 8 Gy, most efficiently mitigated ARS with highly significant increase in mouse survival.
← all excerpts
Alleviation of acute radiation-induced bone marrow failure in mice with human fetal placental stromal cell therapy.
1
—
—